Retraction: Overexpression of NR4A1 is associated with tumor recurrence and poor survival in non-small-cell lung carcinoma

Bing Zhu; Jian-Ru Yang; Yang Jia; Pei Zhang; Lin Shen; Xiao-Long Li; Jing Li; Bing Wang

doi:10.18632/oncotarget.28396

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Retraction:

Retraction: Overexpression of NR4A1 is associated with tumor recurrence and poor survival in non-small-cell lung carcinoma

PDF | How to cite

Oncotarget. 2023; 14:242-242. https://doi.org/10.18632/oncotarget.28396

Metrics: PDF 772 views | ?

Bing Zhu^1,*, Jian-Ru Yang^2,*, Yang Jia³, Pei Zhang¹, Lin Shen¹, Xiao-Long Li¹, Jing Li¹ and Bing Wang¹

¹Department of Cardiothoracic Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, P.R. China
²Central Laboratory, Handan Infectious Diseases Hospital, Handan 056002, P.R. China
³Department of General Practice, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, P.R. China
^*These authors have contributed equally to this work

Published: March 24, 2023

Copyright: © 2023 Zhu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

This article has been retracted: Oncotarget is retracting this article at the request of the Scientific Integrity office. Similarities were found between images in this article and in other articles:

BMC Cancer (2017), https://doi.org/10.1186/s12885-017-3132-9
Disease Markers (2017), https://doi.org/10.1155/2017/6136401

Reader concerns were initially reported in a Pubpeer thread (https://pubpeer.com/publications/1D3EFEEE1E55BFC3B47D193AEFECE6).

Image analysis performed by the Oncotarget Scientific Integrity Office confirmed the findings of fraudulent image duplication. All authors have agreed to this retraction.

Original article: Oncotarget. 2017; 8:1139777–113986. DOI: https://doi.org/10.18632/oncotarget.23048

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 28396

Publication Alerts

Post-Publication Promotion

Retraction:

Retraction: Overexpression of NR4A1 is associated with tumor recurrence and poor survival in non-small-cell lung carcinoma